← Back to Search

Behavioral Intervention

Multicomponent Training Intervention for Sarcopenia

N/A

Recruiting

Led By Brenda Goodrich, DO

Research Sponsored by Geisinger Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age greater than or equal to 65 years

A score greater than 4 on the Strength, Assistance with walking, Rising from a chair, Climbing stairs and Falls questionnaire (SARC-F)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up prior to the start of the intervention (week 1), mid-point of the intervention (week 4), following the completion of the intervention (week 8)

Awards & highlights

Study Summary

This trial aims to see if older adults with muscle loss will feel better and perform better after an 8-week exercise program compared to a group that does not exercise. They will also ask the participants about

Who is the study for?

This trial is for community-dwelling older adults aged 65 or above with probable sarcopenia, as indicated by specific scores on the SARC-F questionnaire and hand grip strength tests. Participants must be able to consent and be patients at the Geisinger 65Forward Scranton clinic.Check my eligibility

What is being tested?

The study is testing an 8-week multicomponent exercise training program's effectiveness in improving physical performance and patient-reported outcomes for older adults with muscle loss, compared to a control group not receiving the intervention.See study design

What are the potential side effects?

While not explicitly listed, potential side effects may include typical exercise-related risks such as muscle soreness, fatigue, joint pain or injury. However, these are generally mild and manageable.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 65 years old or older.

Select...

I scored over 4 on a physical ability questionnaire.

Select...

My hand grip strength is below the required level for my gender.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ prior to the start of the intervention (week 1), mid-point of the intervention (week 4), following the completion of the intervention (week 8)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~prior to the start of the intervention (week 1), mid-point of the intervention (week 4), following the completion of the intervention (week 8)

This trial's timeline: 3 weeks for screening, Varies for treatment, and prior to the start of the intervention (week 1), mid-point of the intervention (week 4), following the completion of the intervention (week 8) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Falls Efficacy Scale-International (FES-I) score

Sarcopenia Quality of Life (SarQoL) score

Short Physical Performance Battery (SPPB) composite score

Secondary outcome measures

Hand Grip Strength score

Other outcome measures

Qualitative Data from semi-structured interviews

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Multicomponent Training InterventionExperimental Treatment1 Intervention

Subjects in the intervention group will attend two standardized group-based sixty-minute sessions per week in the outpatient medical center and will be asked not to change their current physical activity regimen during the 8-week duration of the study.

Group II: Control GroupActive Control1 Intervention

Subjects in the control group will be asked to not change their current level of physical activity during the 8-week duration of the study.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Geisinger ClinicLead Sponsor

149 Previous Clinical Trials

1,886,110 Total Patients Enrolled

Shala Davis, PhDStudy ChairEast Stroudsburg University

Brenda Goodrich, DOPrincipal InvestigatorGeisinger Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are potential candidates still eligible to participate in this ongoing clinical trial?

"Indeed, the information provided on clinicaltrials.gov highlights that this research project is actively seeking eligible participants. The trial was initially listed on February 1st, 2024 and last updated on February 19th, 2024. This investigation aims to enroll a total of 25 subjects across one designated site."

Answered by AI

What is the current number of participants being enrolled in this research trial?

"Affirmative. The data available on clinicaltrials.gov indicates that this investigation is actively seeking participants. Initially shared on February 1st, 2024 and last modified on February 19th, 2024, the study aims to recruit a total of 25 patients from one designated site."

Answered by AI

Recent research and studies

Age and AgeingJournal

The Falls Efficacy Scale International (FES-I). A Comprehensive Longitudinal Validation Study

Delbaere, K., J. C. T. Close, A. S. Mikolaizak, P. S. Sachdev, H. Brodaty, and S. R. Lord. 2010. “The Falls Efficacy Scale International (FES-I). A Comprehensive Longitudinal Validation Study”. Age and Ageing. Oxford University Press (OUP). doi:10.1093/ageing/afp225.

The Journals of Gerontology Series A: Biological Sciences and Medical SciencesJournal

The Lifestyle Interventions and Independence for Elders Study: Design and Methods

Fielding, R. A., W. J. Rejeski, S. Blair, T. Church, M. A. Espeland, T. M. Gill, J. M. Guralnik, et al.. 2011. “The Lifestyle Interventions and Independence for Elders Study: Design and Methods”. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. Oxford University Press (OUP). doi:10.1093/gerona/glr123.

clinicaltrials.govStudy

Effects of Multicomponent Training on Sarcopenia

2024. "Effects of Multicomponent Training on Sarcopenia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06094413.

All > Sarcopenia